Skip to main content
. Author manuscript; available in PMC: 2014 Jun 15.
Published in final edited form as: Int J Cancer. 2012 Dec 13;132(12):2928–2939. doi: 10.1002/ijc.27960

Table 2.

Associations between BMP-related genes and risk of breast cancer overall and by ER/PR status

Overall ER + PR +1 ER + PR − ER − PR + ER − PR −
Controls Cases (N=1292 cases) (N=235 cases) (N=41 cases) (N=411 cases)
N N OR2 (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
ACVR1 (rs2033962)
 GG 2940 2452 1.00 1.00 1.00 1.00 1.00
 GT/TT 1159 1081 1.09 (0.99, 1.20) 1.27 (1.11, 1.46) 0.96 (0.71, 1.29) 0.94 (0.46, 1.90) 1.13 (0.91, 1.42)
ACVR1 (rs4380178)
 GG 3046 2538 1.00 1.00 1.00 1.00 1.00
 GA/AA 1053 997 1.12 (1.01, 1.24) 1.25 (1.08, 1.44) 0.96 (0.71, 1.30) 1.01 (0.50, 2.04) 1.25 (1.00, 1.57)
ACVR1 (rs920522)
 TT 3501 2970 1.00 1.00 1.00 1.00 1.00
 TC/CC 601 565 1.13 (1.00, 1.28) 1.33 (1.12, 1.59) 1.43 (1.01, 2.03) 0.79 (0.31, 2.04) 0.94 (0.70, 1.27)
ACVR1 (rs17182166)
 GG/GT 4051 3466 1.00 1.00 1.00 1.00 1.00
 TT 51 68 1.40 (0.97, 2.03) 1.47 (0.93, 2.33) 1.27 (0.49, 3.24) 1.66 (0.22, 12.62) 2.12 (1.13, 3.97)
ACVR1 (rs1146035)
 GG 2958 2467 1.00 1.00 1.00 1.00 1.00
 GT/TT 1144 1066 1.08 (0.98, 1.20) 1.26 (1.10, 1.45) 0.97 (0.72, 1.30) 1.02 (0.52, 2.03) 1.10 (0.88, 1.38)
ACVR1 (rs10497191)
 CC 3050 2578 1.00 1.00 1.00 1.00 1.00
 CT/TT 1050 957 1.09 (0.98, 1.21) 1.20 (1.04, 1.39) 1.23 (0.92, 1.66) 0.92 (0.45, 1.89) 1.06 (0.84, 1.33)
ACVR1 (rs10497192)
 TT 2206 1852 1.00 1.00 1.00 1.00 1.00
 TC 1606 1409 1.04 (0.95, 1.15) 1.20 (1.05, 1.38) 1.01 (0.76, 1.34) 0.86 (0.45, 1.66) 1.08 (0.87, 1.34)
 CC 290 274 1.13 (0.94, 1.35) 1.39 (1.09, 1.77) 1.13 (0.68, 1.87) 0.84 (0.25, 2.85) 1.02 (0.68, 1.53)
ACVR1 (rs4233672)
 GG 2764 2303 1.00 1.00 1.00 1.00 1.00
 GA/AA 1337 1231 1.10 (1.00, 1.21) 1.22 (1.07, 1.40) 0.99 (0.75, 1.32) 0.95 (0.48, 1.85) 1.14 (0.92, 1.41)
ACVR1 (rs10933443)
 TT 2341 1994 1.00 1.00 1.00 1.00 1.00
 TC/CC 1756 1538 1.02 (0.93, 1.12) 1.19 (1.04, 1.35) 1.00 (0.76, 1.31) 1.21 (0.65, 2.26) 1.07 (0.87, 1.32)
ACVR1 (rs2883605)
 GG 3568 3047 1.00 1.00 1.00 1.00 1.00
 GT/TT 483 438 1.00 (0.87, 1.15) 1.06 (0.87, 1.28) 0.59 (0.37, 0.95) 0.95 (0.37, 2.48) 1.11 (0.82, 1.49)
ACVR1 (rs10497193)
 AA/AG 4002 3447 1.00 1.00 1.00 1.00 1.00
 GG 99 87 1.04 (0.77, 1.39) 1.01 (0.66, 1.53) 2.07 (1.08, 3.98) 1.76 (0.41, 7.51) 0.80 (0.40, 1.61)
ACVR1 (rs4664901)
 TT/TC 3891 3338 1.00 1.00 1.00 1.00 1.00
 CC 207 195 1.10 (0.90, 1.35) 1.11 (0.84, 1.48) 1.94 (1.21, 3.11) 1.31 (0.40, 4.32) 1.01 (0.64, 1.58)
ACVRL1 (rs11169953)
 CC 2003 1787 1.00 1.00 1.00 1.00 1.00
 CT/TT 2098 1747 0.91 (0.83, 1.00) 0.93 (0.81, 1.06) 1.05 (0.80, 1.37) 1.31 (0.70, 2.46) 0.73 (0.60, 0.90)
BMP4 (rs17563)
 TT 1449 1056 1.00 1.00 1.00 1.00 1.00
 TC/CC 2376 2159 1.16 (1.05, 1.29) 1.29 (1.10, 1.51) 1.26 (0.90, 1.77) 1.39 (0.64, 3.02) 1.38 (1.06, 1.80)
BMP4 (rs762642)
 TT/TG 3391 2957 1.00 1.00 1.00 1.00 1.00
 GG 710 578 0.93 (0.82, 1.05) 0.96 (0.80, 1.14) 0.62 (0.40, 0.94) 1.26 (0.58, 2.77) 0.90 (0.68, 1.20)
BMP4 (rs2761887)
 AA 1295 1067 1.00 1.00 1.00 1.00 1.00
 AC/CC 2805 2466 1.07 (0.97, 1.18) 1.10 (0.95, 1.27) 1.54 (1.13, 2.11) 1.10 (0.55, 2.16) 1.19 (0.95, 1.50)
BMP4 (rs4898820)
 TT/TG 3147 2743 1.00 1.00 1.00 1.00 1.00
 GG 955 790 0.95 (0.85, 1.06) 0.95 (0.81, 1.11) 0.62 (0.43, 0.90) 1.00 (0.47, 2.11) 0.95 (0.74, 1.22)
BMPR2 (rs12621870)
 TT 2525 2171 1.00 1.00 1.00 1.00 1.00
 TC 1354 1178 1.00 (0.91, 1.10) 1.04 (0.91, 1.20) 0.94 (0.70, 1.25) 1.93 (0.98, 3.77) 0.90 (0.72, 1.13)
 CC 212 174 0.94 (0.76, 1.17) 1.06 (0.79, 1.42) 1.24 (0.71, 2.16) 4.20 (1.62, 10.91) 0.76 (0.45, 1.28)
GDF10 (rs7093975)
 CC 2346 2001 1.00 1.00 1.00 1.00 1.00
 CT 1526 1285 0.97 (0.88, 1.06) 0.93 (0.81, 1.06) 0.90 (0.67, 1.20) 1.61 (0.82, 3.15) 0.96 (0.77, 1.20)
 TT 229 244 1.22 (1.01, 1.48) 1.19 (0.91, 1.56) 1.42 (0.86, 2.33) 3.62 (1.40, 9.41) 1.24 (0.82, 1.89)
GDF10 (rs762454)
 AA 2228 1802 1.00 1.00 1.00 1.00 1.00
 AG 1553 1432 1.12 (1.02, 1.23) 1.13 (0.99, 1.30) 1.26 (0.95, 1.68) 0.65 (0.32, 1.31) 1.02 (0.82, 1.26)
 GG 312 293 1.09 (0.92, 1.30) 1.07 (0.84, 1.36) 1.77 (1.15, 2.71) 1.31 (0.49, 3.50) 0.53 (0.33, 0.87)
GDF10 (rs2853838)
 CC 2554 2197 1.00 1.00 1.00 1.00 1.00
 CA 1379 1182 1.00 (0.90, 1.10) 0.97 (0.84, 1.12) 0.94 (0.71, 1.26) 2.04 (1.06, 3.91) 1.03 (0.82, 1.28)
 AA 169 155 1.09 (0.87, 1.36) 1.07 (0.77, 1.48) 1.24 (0.67, 2.30) 3.85 (1.27, 11.71) 1.33 (0.82, 2.15)
1

Estrogen Receptor (ER) and Progesterone Receptor (PR) data were compared to 3125 controls from sites where cases have ER/PR data

2

Odds Ratios (OR) and 95% Confidence Intervals (CI) adjusted for age, study, BMI in referent year, vigorous activity in referent year, parity, age at first birth, alcohol consumption and genetic admixture; bold text designates significant associations at the 0.05 level after adjustment for multiple comparisons

HHS Vulnerability Disclosure